Unknown

Dataset Information

Cardiac implantable electronic device lead-based masses and atrial fibrillation ablation: a case-based illustration of periprocedural anticoagulation management strategies.


ABSTRACT:

Introduction

Cardiac implantable electronic device (CIED) leads frequently develop echogenic masses. However, the nature of these masses is not well understood. In patients in whom atrial fibrillation (AF) catheter ablation is planned, there is concern that transseptal puncture may result in cerebrovascular embolism of these masses. The optimal therapeutic strategy in this setting remains undefined.

Methods

We describe six patients identified over a 6-year period (2008-2014) with device lead-based masses prior to or at the time of AF ablation. We examined the anticoagulation strategy and periprocedural management based on mass identification.

Results

In all six patients (age 39-73; four males), the device lead mass was found in the right atrium. The average mass size

SUBMITTER: Lenz CJ 

PROVIDER: S-EPMC5077628 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature